In Re Coordinated Pretrial Proceedings in Antibiotic Antitrust Actions

333 F. Supp. 299
District Court, S.D. New York·Decided August 4, 1971·No. M 19-93A·Published·Cited by 24 cases

Opinion

*300 ADMINISTRATIVE ORDER NO. 71-5

MEMORANDUM AND ORDER TRANSFERRING “HUMAN CONSUMPTION CASES” TO THE DISTRICT OF MINNESOTA UNDER 28 U.S.C. § 1404(a)

MILES W. LORD, District Judge

(By Assignment).

On December 2, 1970, the Judicial Panel on Multidistrict Litigation assigned the so-called “non-settling” antibiotic drug cases to the undersigned judge for coordinated or consolidated pretrial proceedings under 28 U.S.C. § 1407. In re Antibiotic Drugs, 320 F.Supp. 586 (Jud.Pan.Mult.Lit.1970). With the exception of the action brought by the United States, all actions subject to this order involve treble damage claims allegedly resulting from purchases, either direct or indirect, of antibiotic drugs for human consumption. 1

The “human consumption” category includes actions brought by states, cities, wholesale and retail drug stores, insurance companies, union welfare funds, the United States of America and two foreign nations. Many of them involve interlocking and overlapping claims. For example, each of the seven litigating states 2 seeks treble damages for reimbursements made by them for drugs purchased by their citizens under state welfare plans. However, the United States provides part of the funds for state welfare programs and it seeks prorata recovery for the same purchases.

*301 Three large health insurance companies 3 seek treble damages allegedly resulting from their payments and inuring to them because of reimbursement for purchases of antibiotic drugs for their subscribers. These claims may be in conflict with both the consumer claims and the private hospital claims asserted by the litigating states. In addition, several union welfare funds also seek treble damages for reimbursed purchases made by their members or for drugs dispensed directly to their members. 4 It would appear that some union welfare funds may be insured by companies which may be included in the “insurance company class” and this would create a direct conflict between the two classes. 5 Finally, Thrifty Drug Stores, one of the largest drug chains on the west coast, seeks treble damages resulting from sales to consumers in several of the litigating states. This presents a direct conflict between Thrifty’s claims and those of the affected states. There may also be a conflict between Thrifty’s claims and those of some of the other “human consumption” plaintiffs. There is also a similar conflict and overlap on the international scene. The United States seeks damages resulting from its purchases of antibiotic drugs for distribution in its foreign aid program. The Republic of Vietnam apparently seeks treble damages resulting from some of the same purchases. As it stands now, many of these conflicting and overlapping cases will have to be tried separately in different districts and by different judges.

The defendants have indicated from the beginning of this litigation that they intend to urge that some of these plaintiffs are too remote or lack standing to assert their claims under the antitrust laws and that others “passed-on” the illegal overcharge (if any) to those who purchased from them. The court soon recognized that these apparent conflicts presented one of the biggest problems in “managing” this litigation and in an unsuccessful attempt to distill the litigation down to more manageable proportions, it encouraged the defendants to file motions to dismiss several categories of plaintiffs on the ground that their claims were too remote or that they lacked standing to assert them. These motions were heard in March in San Francisco and after much deliberation, the court concluded that it could not, at this stage in the proceedings, hold as a matter of law that any of the “human consumption” plaintiffs were too remote or lacked standing to assert their claims. 6 See, State of Minnesota v. U. S. Steel Corp., 438 F.2d 1380 (8th Cir. 1971).

The court had intended, after paring down the litigation, to consolidate several groups of plaintiffs, such as the seven litigating states, for jury trials at least as to liability. As a part of this plan and with the approval of the Chief Justice of the United States, the Judicial Panel on Multidistrict Litigation and the Chief Judges of two circuits involved, this judge was assigned to the Northern District of California under 28 U.S.C. § 292(c) for the purpose of trying the eases originally commenced in that district.

However, since these overlaps and conflicts cannot, in this court’s opinion, be resolved prior to trial, it has become increasingly clear that they can only be satisfactorily resolved by a coordinated or consolidated trial or trials in one district directed by the judge who is most familiar with this massive litigation. 7 *302 This led to the court’s tenative conclusion that the transfer of all human consumption cases to a single district for trial purposes was a prerequisite to working out a realistic “trial plan” for them. Therefore, on April 5, 1971, this court ordered the parties to show cause why all human consumption cases (except the competitor cases) should not be transferred to the District of Minnesota pursuant to 28 U.S.C. § 1404(a). A hearing was held in New York City on May 5, 1971, and all parties had a full opportunity to present their views.

All defendants vigorously oppose the transfer of these cases to the District of Minnesota for trial and one of them, Chas. Pfizer & Co., seems to be categorically opposed to the transfer and consolidation of any of these cases for trial. Apparently Pfizer would prefer to try these 31 separate actions in the eleven districts in which they were filed. 8 The plaintiffs generally favor transfer to a single district and approve of the selection of the District of Minnesota.

I.

The threshold question is whether this judge, as a transferee judge, has the authority to transfer actions transferred to the court under section 1407 to another district under section 1404 (a). 9 In a comprehensive and typically well-written brief, the defendants point out quite correctly that Congress clearly limited the power of the Judicial Panel on Multidistrict Litigation to transfers for “coordinated or consolidated pretrial proceedings” and that it has no author

Free access — add to your briefcase to read the full text and ask questions with AI

In Re Coordinated Pretrial Proceedings in Antibiotic Antitrust Actions, 333 F. Supp. 299 (S.D.N.Y. 1971).

333 F. Supp. 299 (In Re Coordinated Pretrial Proceedings in Antibiotic Antitrust Actions) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

In Re Air Crash Disaster at Stapleton Intern.
720 F. Supp. 1455 (D. Colorado, 1988)
Ford v. Continental Airlines Corp.
720 F. Supp. 1455 (D. Colorado, 1988)
In re "Agent Orange" Product Liability Litigation
100 F.R.D. 718 (E.D. New York, 1983)
In Re Longhorn Securities Litigation
573 F. Supp. 274 (W.D. Oklahoma, 1983)
Hoyt Construction Co. v. Alside, Inc.
538 F. Supp. 45 (D. Minnesota, 1982)
In Re Exterior Siding and Aluminum Coil Litigation
538 F. Supp. 45 (D. Minnesota, 1982)
R. A. Hanson Co. v. Aetna Casualty & Surety Co.
550 P.2d 701 (Court of Appeals of Washington, 1976)
In Re Aircrash Near Duarte, California, on June 6, 1971
357 F. Supp. 1013 (C.D. California, 1973)
Elwonger v. Career Academy, Inc.
57 F.R.D. 569 (E.D. Wisconsin, 1972)
In Re Air Crash Disaster at Toronto International Airport on July 5, 1970
346 F. Supp. 533 (Judicial Panel on Multidistrict Litigation, 1972)
In Re Air Crash Disaster at Huntington, West Virginia
342 F. Supp. 1400 (Judicial Panel on Multidistrict Litigation, 1972)
In Re CBS Color Tube Patent Litigation
342 F. Supp. 1403 (Judicial Panel on Multidistrict Litigation, 1972)